Beryl Drugs

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue8.097.663.216.295.64
Expenses7.767.283.635.795.53
EBITDA0.710.800.030.980.56
EBIT0.430.49-0.290.710.23
Profit Before Tax0.320.38-0.430.500.11
Net Profit0.270.31-0.350.370.01
Financial Ratios
Operating Profit Margin8.97%10.50%1.01%15.84%10.16%
Net Profit Margin3.36%4.07%-11.74%5.92%0.18%
Earning Per Share (Diluted)0.540.61-0.680.730.01
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ